Patterns of Failure for Stage I Ampulla of Vater Adenocarcinoma: A Single Institutional Experience
Zhong, J, Palta, M, Willett, C.G, McCall, S.J, McSherry, F, Uronis, H.E, Tyler, D.S, Czito, B.G
Published in International journal of radiation oncology, biology, physics (01.10.2013)
Published in International journal of radiation oncology, biology, physics (01.10.2013)
Get full text
Journal Article
398 POSTER Phase I, pharmacokinetic (PK), dose-escalation study of EZN-2968, a novel hypoxia-inducible factor-1 alpha (HIF-1a) antagonist, administered weekly in patients (pts) with solid tumours
Lewis, N, Cohen, R.B, Nishida, Y, Hurwitz, H.I, Arrowwood, C, Uronis, H.E, Gamza, F, Longley, C, Buchbinder, A, Figueroa, J
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
Novel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial
Wang, J., Liu, S.V., Uronis, H.E., Wu, C., Mahalingam, D., Spira, A., Carter, L., Hu, X., Weems, G., Wilkins, H.J., Duska, L.R., Kelly, K.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Biomarker-guided enrichment of the antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients with advanced HER2+ gastric adenocarcinoma (GEA)
Catenacci, D.V.T., Park, H., Uronis, H.E., Kang, Y.-K., Ng, M., Gold, P., Lacy, J., Enzinger, P.C., Park, S., Lee, K.-W., Yen, J., Odegaard, J., Franovic, A., Baughman, J., Muth, J., Wynter-Horton, A., Wu, T., Wigginton, J., Davidson-Moncada, J.K., Bang, Y.-J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article